Company profile: Abcam
1.1 - Company Overview
Company description
- Provider of antibodies, proteins, and kits and reagents for life science research, validated for research use to support scientific studies and facilitate experimental procedures. Helps researchers with breakthroughs in cancer, neurological disorders, infectious diseases, and metabolic disorders.
Products and services
- Antibodies: Abcam delivers a wide range of validated antibodies for research use, supporting studies in cancer, neurological, infectious, and metabolic disorders across diverse life-science experiments
- Kits and Reagents: Abcam supplies life-science research kits and reagents that facilitate experimental procedures in cancer, neuroscience, infectious disease, and metabolic studies
- Proteins: Abcam offers proteins for research applications aiding the study of biological processes in cancer, neurological, infectious, and metabolic disorders
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Abcam
Element Biosciences
HQ: United States
Website
- Description: Provider of innovative genetic analysis tools, including the AVITI System benchtop sequencer with dual flow cell capacity; AVITI24 integrating sequencing and Teton CytoProfiling to analyze DNA, RNA, proteins, and cell morphology from a single sample; Teton Assays targeting oncology, immunology, neuroscience; Cloudbreak Freestyle Kits to streamline AVITI workflows; and Avidity Sequencing for highly accurate, efficient data.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Element Biosciences company profile →
Healionics
HQ: United States
Website
- Description: Provider of synthetic vascular grafts and platform biomaterial scaffolds for dialysis patients and tissue regeneration. Offers STARgraft for reliable bloodstream access with resistance to occlusion and infection, and STAR Biomaterial with specific pore structure to enable angiogenesis and minimize foreign body response.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Healionics company profile →
BBI Group
HQ: United Kingdom
Website
- Description: Provider of diagnostic products to multiple industries, founded on superior gold reagents. A trusted partner to leading diagnostic and healthcare organisations for over 25 years, with three businesses delivering excellence in diagnostic assay development and manufacturing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BBI Group company profile →
Union Biometrica
HQ: United States
Website
- Description: Provider of high-throughput large-particle (10-1500 micron) flow cytometry systems for analyzing, sorting and dispensing objects too large or fragile for traditional cytometers. Products include COPAS FP, BioSorter and VISION for sorting by size, length, optical density and multiple fluorescence channels. Systems handle cells, cell clusters and small model organisms. VAST BioImager enables automated high-throughput, high-content screening and cellular-resolution imaging of zebrafish larvae.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Union Biometrica company profile →
Artesyn Biosolutions
HQ: Ireland
Website
- Description: Provider of single-use valves, components, and systems for the biopharmaceutical industry, designed and manufactured to support increased efficiency in biopharmaceutical production.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Artesyn Biosolutions company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Abcam
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Abcam
2.2 - Growth funds investing in similar companies to Abcam
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Abcam
4.2 - Public trading comparable groups for Abcam
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →